About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study of Procoagulation Markers in Stroke Patients | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT01811550

Study of Procoagulation Markers in Stroke Patients

The Insights on Selected Procoagulation Markers and Outcomes in Stroke Trial (I-SPOT): Response to Insulin Administration and Blood Glucose Control proposal is designed to accompany the Stroke Hypergl...

Lead sponsor: Temple University•38 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Temple University

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)
Neurological Emergencies Treatment Trials Network (NETT)
University of Virginia
University of Michigan
Medical University of South Carolina
Augusta University

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Enrolled in SHINE study
•Ability to give Informed Consent (self or LAR)

Exclusion Criteria

•Current or planned use of full dose anticoagulation from baseline to the 48 hour sample collection
•Known moderate or severe hepatic insufficiency (as defined by INR\>1.5 if known or history of variceal bleeding or hepatic encephalopathy)
•Prior or concurrent thrombotic or hypercoagulable condition (Antiphospholipid antibody syndrome; Antithrombin III, Protein C or S deficiencies; Congenital or Inherited Factor deficiencies; sickle cell disease)

Related studies

Effects of Wearable Vibratory Devices on Arm Function in Subacute Stroke Patients

NCT07641790 · Hemiplegia, Stroke

Telerehabilitation In The Home After Stroke

NCT06682429 · Stroke

Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation

NCT07441382 · Atrial Fibrillation (AF), Stroke, and more

Brain-controlled Spinal Cord Stimulation in Participants With Chronic Stroke for Lower and Upper Limb Rehabilitation

NCT07610850 · Stroke, Hemiplegia

kTMP-Enhanced Motor Rehabilitation for Chronic Stroke Recovery (KULMINATE) Pilot

NCT07631078 · Stroke, Chronic Stroke Patients, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 30, 2020Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment271

Start dateAug 2012

Last updatedApr 30, 2020

Condition

Stroke Hyperglycemia Procoagulation Markers

Locations shown

Banner University Medical Center

Tucson, Arizona

Long Beach Memorial Hospital

Long Beach, California

Ronald Regan Medical Center

Los Angeles, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 30, 2020Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions